Obesity as a Chronic Disease: SA Pushes for Treatment Access

Learn how acknowledging obesity as a chronic disease can transform healthcare approaches and reduce long-term health costs.
Generic Semaglutide in India: Affordable Treatment Options

Learn how the advent of Generic Semaglutide in India will change the landscape of weight-loss and diabetes medications.
Generic Semaglutide Pricing Could Disrupt Global Markets

Discover the potential of Generic Semaglutide Pricing, where new research shows significant savings on weight-loss medications.
Eli Lilly 2026 Guidance Signals Momentum In Obesity Care
Eli Lilly has forecast 2026 profit and revenue above Wall Street expectations, reinforcing how fast the obesity market is reshaping Big Pharma growth plans. The recent Eli Lilly 2026 Guidance reflects the company’s confidence in strong future performance. The company also beat estimates for fourth-quarter earnings, helped by strong demand for its injectable weight-loss and…...
Generic Semaglutide Set to Disrupt Global GLP‑1 Market
Aspen Pharmacare is lining up a generic semaglutide launch in Canada, promising big discounts, and widening GLP-1 access.
GLP-1 Weight Loss Drugs Reshape Obesity Care In South Africa
GLP-1 weight loss drugs like Mounjaro and Wegovy are transforming obesity treatment in SA amid rising health concerns and systemic barriers.
Wegovy Weight-Loss Pill Offers Injectables Alternative
Explore the benefits of the Wegovy weight-loss pill as a revolutionary option in managing obesity effectively.
Obesity Drug Deal: Trump Cuts Prices for Patients
The landmark obesity drug deal announced by Trump aims to make weight management drugs more affordable for millions of patients.
GLP-1 Drugs Lower Cancer Rates in Weight Loss Study
Find out how GLP-1 drugs like Ozempic and Wegovy can lower cancer risk while aiding in weight loss and diabetes control.
Novo Nordisk Hiring Freeze After Wegovy Sales Decline
Novo Nordisk implements a hiring freeze as layoffs approach after Wegovy's success. Discover the impact on the pharmaceutical industry.